ID   CHST6_HUMAN             Reviewed;         395 AA.
AC   Q9GZX3; D3DUK3;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   10-MAY-2017, entry version 134.
DE   RecName: Full=Carbohydrate sulfotransferase 6;
DE            EC=2.8.2.-;
DE   AltName: Full=Corneal N-acetylglucosamine-6-O-sulfotransferase;
DE            Short=C-GlcNAc6ST;
DE            Short=hCGn6ST;
DE   AltName: Full=Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta;
DE            Short=GST4-beta;
DE   AltName: Full=N-acetylglucosamine 6-O-sulfotransferase 5;
DE            Short=GlcNAc6ST-5;
DE            Short=Gn6st-5;
GN   Name=CHST6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], TISSUE SPECIFICITY, AND
RP   VARIANTS MCD CYS-50; ARG-174; GLU-203; TRP-211 AND LYS-274.
RX   PubMed=11017086; DOI=10.1038/79987;
RA   Akama T.O., Nishida K., Nakayama J., Watanabe H., Ozaki K.,
RA   Nakamura T., Dota A., Kawasaki S., Inoue Y., Maeda N., Yamamoto S.,
RA   Fujiwara T., Thonar E.J.-M.A., Shimomura Y., Kinoshita S.,
RA   Tanigami A., Fukuda M.N.;
RT   "Macular corneal dystrophy type I and type II are caused by distinct
RT   mutations in a new sulphotransferase gene.";
RL   Nat. Genet. 26:237-241(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=11181564; DOI=10.1093/glycob/11.1.75;
RA   Hemmerich S., Lee J.K., Bhakta S., Bistrup A., Ruddle N.R.,
RA   Rosen S.D.;
RT   "Chromosomal localization and genomic organization for the galactose/
RT   N-acetylgalactosamine/N-acetylglucosamine 6-O-sulfotransferase gene
RT   family.";
RL   Glycobiology 11:75-87(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=11352640; DOI=10.1006/bbrc.2001.4668;
RA   Bartes A., Bhakta S., Hemmerich S.;
RT   "Sulfation of endothelial mucin by corneal keratan N-acetylglucosamine
RT   6-O-sulfotransferase (GST-4beta).";
RL   Biochem. Biophys. Res. Commun. 282:928-933(2001).
RN   [6]
RP   FUNCTION, SUBSTRATE SPECIFICITY, AND VARIANTS MCD CYS-50; ARG-174;
RP   GLU-203; TRP-211; THR-217 AND LYS-274.
RX   PubMed=12218059; DOI=10.1074/jbc.M207412200;
RA   Akama T.O., Misra A.K., Hindsgaul O., Fukuda M.N.;
RT   "Enzymatic synthesis in vitro of the disulfated disaccharide unit of
RT   corneal keratan sulfate.";
RL   J. Biol. Chem. 277:42505-42513(2002).
RN   [7]
RP   VARIANTS MCD VAL-128 AND PRO-166.
RX   PubMed=11139648;
RA   Liu N.-P., Dew-Knight S., Rayner M., Jonasson F., Akama T.O.,
RA   Fukuda M.N., Bao W., Gilbert J.R., Vance J.M., Klintworth G.K.;
RT   "Mutations in corneal carbohydrate sulfotransferase 6 gene (CHST6)
RT   cause macular corneal dystrophy in Iceland.";
RL   Mol. Vis. 6:261-264(2000).
RN   [8]
RP   VARIANTS MCD SER-31; SER-72; SER-107; ARG-200 AND VAL-206.
RX   PubMed=11818380;
RA   El-Ashry M.F., El-Aziz M.M., Wilkins S., Cheetham M.E., Wilkie S.E.,
RA   Hardcastle A.J., Halford S., Bayoumi A.Y., Ficker L.A., Tuft S.,
RA   Bhattacharya S.S., Ebenezer N.D.;
RT   "Identification of novel mutations in the carbohydrate
RT   sulfotransferase gene (CHST6) causing macular corneal dystrophy.";
RL   Invest. Ophthalmol. Vis. Sci. 43:377-382(2002).
RN   [9]
RP   VARIANTS MCD PRO-15; THR-61; HIS-68; LEU-70; GLY-102; PRO-131;
RP   PRO-152; PRO-166; ARG-200 AND GLN-204.
RX   PubMed=12824236; DOI=10.1167/iovs.02-0740;
RA   Niel F., Ellies P., Dighiero P., Soria J., Sabbagh C., San C.,
RA   Renard G., Delpech M., Valleix S.;
RT   "Truncating mutations in the carbohydrate sulfotransferase 6 gene
RT   (CHST6) result in macular corneal dystrophy.";
RL   Invest. Ophthalmol. Vis. Sci. 44:2949-2953(2003).
RN   [10]
RP   VARIANTS MCD HIS-177; GLN-204; LEU-205; TRP-211 AND THR-217.
RX   PubMed=12882769; DOI=10.1167/iovs.02-0910;
RA   Iida-Hasegawa N., Furuhata A., Hayatsu H., Murakami A., Fujiki K.,
RA   Nakayasu K., Kanai A.;
RT   "Mutations in the CHST6 gene in patients with macular corneal
RT   dystrophy: immunohistochemical evidence of heterogeneity.";
RL   Invest. Ophthalmol. Vis. Sci. 44:3272-3277(2003).
RN   [11]
RP   VARIANT MCD GLN-211.
RX   PubMed=12883341; DOI=10.1097/00003226-200308000-00004;
RA   Ha N.T., Chau H.M., Cung le X., Thanh T.K., Fujiki K., Murakami A.,
RA   Hiratsuka Y., Hasegawa N., Kanai A.;
RT   "Identification of novel mutations of the CHST6 gene in Vietnamese
RT   families affected with macular corneal dystrophy in two generations.";
RL   Cornea 22:508-511(2003).
RN   [12]
RP   VARIANTS MCD LEU-51; PRO-59; LEU-66; MET-76; GLN-211; GLN-211; CYS-268
RP   AND CYS-268.
RX   PubMed=12882775; DOI=10.1167/iovs.03-0031;
RA   Ha N.T., Chau H.M., Cung le X., Thanh T.K., Fujiki K., Murakami A.,
RA   Hiratsuka Y., Kanai A.;
RT   "Mutation analysis of the carbohydrate sulfotransferase gene in
RT   Vietnamese with macular corneal dystrophy.";
RL   Invest. Ophthalmol. Vis. Sci. 44:3310-3316(2003).
RN   [13]
RP   VARIANTS MCD ARG-22; TYR-42; LEU-53; HIS-93; PRO-97; TYR-102; CYS-127;
RP   GLN-205; THR-206; PRO-249 AND LYS-274.
RX   PubMed=14609920; DOI=10.1001/archopht.121.11.1608;
RA   Warren J.F., Aldave A.J., Srinivasan M., Thonar E.J., Kumar A.B.,
RA   Cevallos V., Whitcher J.P., Margolis T.P.;
RT   "Novel mutations in the CHST6 gene associated with macular corneal
RT   dystrophy in southern India.";
RL   Arch. Ophthalmol. 121:1608-1612(2003).
RN   [14]
RP   VARIANTS MCD ASP-52; LEU-53; TRP-98; SER-107; LEU-121; SER-202;
RP   GLN-204; PHE-210; GLU-221 AND TYR-221.
RX   PubMed=14735064;
RA   Sultana A., Sridhar M.S., Jagannathan A., Balasubramanian D.,
RA   Kannabiran C., Klintworth G.K.;
RT   "Novel mutations of the carbohydrate sulfotransferase-6 (CHST6) gene
RT   causing macular corneal dystrophy in India.";
RL   Mol. Vis. 9:730-734(2003).
RN   [15]
RP   VARIANTS MCD GLY-102; GLY-162; GLU-198 AND ARG-200.
RX   PubMed=14984470; DOI=10.1111/j.0009-9163.2004.00191.x;
RA   Abbruzzese C., Kuhn U., Molina F., Rama P., De Luca M.;
RT   "Novel mutations in the CHST6 gene causing macular corneal
RT   dystrophy.";
RL   Clin. Genet. 65:120-125(2004).
RN   [16]
RP   VARIANTS MCD LEU-51; SER-72; GLY-102; VAL-104; CYS-110; PRO-122;
RP   ARG-200 AND PRO-276.
RX   PubMed=15013869; DOI=10.1016/j.ajo.2003.09.036;
RA   Aldave A.J., Yellore V.S., Thonar E.J., Udar N., Warren J.F.,
RA   Yoon M.K., Cohen E.J., Rapuano C.J., Laibson P.R., Margolis T.P.,
RA   Small K.;
RT   "Novel mutations in the carbohydrate sulfotransferase gene (CHST6) in
RT   American patients with macular corneal dystrophy.";
RL   Am. J. Ophthalmol. 137:465-473(2004).
RN   [17]
RP   VARIANTS MCD ARG-200; PRO-276 AND ASP-358.
RX   PubMed=15652851; DOI=10.1016/j.ajo.2004.07.001;
RA   El-Ashry M.F., Abd El-Aziz M.M., Shalaby O., Wilkins S.,
RA   Poopalasundaram S., Cheetham M., Tuft S.J., Hardcastle A.J.,
RA   Bhattacharya S.S., Ebenezer N.D.;
RT   "Novel CHST6 nonsense and missense mutations responsible for macular
RT   corneal dystrophy.";
RL   Am. J. Ophthalmol. 139:192-193(2005).
RN   [18]
RP   VARIANT MCD HIS-358.
RX   PubMed=19365571;
RA   Dang X., Zhu Q., Wang L., Su H., Lin H., Zhou N., Liang T., Wang Z.,
RA   Huang S., Ren Q., Qi Y.;
RT   "Macular corneal dystrophy in a Chinese family related with novel
RT   mutations of CHST6.";
RL   Mol. Vis. 15:700-705(2009).
RN   [19]
RP   VARIANTS MCD GLY-177; ARG-186 AND GLN-211.
RX   PubMed=21242781; DOI=10.1097/ICO.0b013e3182012888;
RA   Patel D.A., Harocopos G.J., Chang S.H., Vora S.C., Lubniewski A.J.,
RA   Huang A.J.;
RT   "Novel CHST6 gene mutations in 2 unrelated cases of macular corneal
RT   dystrophy.";
RL   Cornea 30:664-669(2011).
RN   [20]
RP   VARIANT MCD TRP-205.
RX   PubMed=24311932; DOI=10.3341/kjo.2013.27.6.454;
RA   Lee Y.K., Chang D.J., Chung S.K.;
RT   "A case of Korean patient with macular corneal dystrophy associated
RT   with novel mutation in the CHST6 gene.";
RL   Korean J. Ophthalmol. 27:454-458(2013).
RN   [21]
RP   VARIANTS MCD PHE-118; ARG-174; ARG-186; TRP-205; LYS-274; TYR-308 AND
RP   HIS-358.
RX   PubMed=26604660;
RA   Park S.H., Ahn Y.J., Chae H., Kim Y., Kim M.S., Kim M.;
RT   "Molecular analysis of the CHST6 gene in Korean patients with macular
RT   corneal dystrophy: Identification of three novel mutations.";
RL   Mol. Vis. 21:1201-1209(2015).
CC   -!- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl
CC       sulfate (PAPS) as sulfonate donor to catalyze the transfer of
CC       sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc)
CC       residues of keratan. Mediates sulfation of keratan in cornea.
CC       Keratan sulfate plays a central role in maintaining corneal
CC       transparency. Acts on the non-reducing terminal GlcNAc of short
CC       and long carbohydrate substrates that have poly-N-
CC       acetyllactosamine structures. {ECO:0000269|PubMed:11352640,
CC       ECO:0000269|PubMed:12218059}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000250};
CC       Single-pass type II membrane protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in cornea. Mainly expressed in
CC       brain. Also expressed in spinal cord and trachea.
CC       {ECO:0000269|PubMed:11017086, ECO:0000269|PubMed:11181564,
CC       ECO:0000269|PubMed:11352640}.
CC   -!- DISEASE: Macular dystrophy, corneal (MCD) [MIM:217800]: An ocular
CC       disease characterized by bilateral, progressive corneal
CC       opacification, and reduced corneal sensitivity. Onset occurs in
CC       the first decade, usually between ages 5 and 9. Painful attacks
CC       with photophobia, foreign body sensations, and recurrent erosions
CC       occur in most patients. The disease is due to deposition of an
CC       unsulfated keratan sulfate both within the intracellular space
CC       (within the keratocytes and endothelial cells) and in the
CC       extracellular corneal stroma. Macular corneal dystrophy is divided
CC       into the clinically indistinguishable types I, IA, and II based on
CC       analysis of the normally sulfated, or antigenic, keratan sulfate
CC       levels in serum and immunohistochemical evaluation of the cornea.
CC       Patients with types I and IA macular corneal dystrophy have
CC       undetectable serum levels of antigenic keratan sulfate, whereas
CC       those with type II macular corneal dystrophy have normal or low
CC       levels, depending on the population examined.
CC       {ECO:0000269|PubMed:11017086, ECO:0000269|PubMed:11139648,
CC       ECO:0000269|PubMed:11818380, ECO:0000269|PubMed:12218059,
CC       ECO:0000269|PubMed:12824236, ECO:0000269|PubMed:12882769,
CC       ECO:0000269|PubMed:12882775, ECO:0000269|PubMed:12883341,
CC       ECO:0000269|PubMed:14609920, ECO:0000269|PubMed:14735064,
CC       ECO:0000269|PubMed:14984470, ECO:0000269|PubMed:15013869,
CC       ECO:0000269|PubMed:15652851, ECO:0000269|PubMed:19365571,
CC       ECO:0000269|PubMed:21242781, ECO:0000269|PubMed:24311932,
CC       ECO:0000269|PubMed:26604660}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry. CHST6
CC       homozygous missense mutations have been observed in patients with
CC       macular corneal dystrophy type I, while type II patients show a
CC       large deletion and replacement in the upstream region of CHST6.
CC       The only missense mutation for type II is Cys-50, which is
CC       heterozygous with a replacement in the upstream region on the
CC       other allele of CHST6.
CC   -!- SIMILARITY: Belongs to the sulfotransferase 1 family.
CC       Gal/GlcNAc/GalNAc subfamily. {ECO:0000305}.
CC   -!- CAUTION: PubMed:12824236 reported a Gly-204 variant, however
CC       according to their results reported in figure 1, it is a Gln-204
CC       variant. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF219990; AAG26325.1; -; mRNA.
DR   EMBL; AF219991; AAG26327.1; -; Genomic_DNA.
DR   EMBL; AF280086; AAG48244.1; -; mRNA.
DR   EMBL; CH471114; EAW95640.1; -; Genomic_DNA.
DR   EMBL; CH471114; EAW95641.1; -; Genomic_DNA.
DR   EMBL; BC074883; AAH74883.1; -; mRNA.
DR   EMBL; BC074834; AAH74834.1; -; mRNA.
DR   CCDS; CCDS10918.1; -.
DR   RefSeq; NP_067628.1; NM_021615.4.
DR   RefSeq; XP_005256012.1; XM_005255955.4.
DR   RefSeq; XP_011521387.1; XM_011523085.2.
DR   UniGene; Hs.655622; -.
DR   ProteinModelPortal; Q9GZX3; -.
DR   BioGrid; 110334; 13.
DR   STRING; 9606.ENSP00000328983; -.
DR   iPTMnet; Q9GZX3; -.
DR   PhosphoSitePlus; Q9GZX3; -.
DR   BioMuta; CHST6; -.
DR   EPD; Q9GZX3; -.
DR   PaxDb; Q9GZX3; -.
DR   PeptideAtlas; Q9GZX3; -.
DR   PRIDE; Q9GZX3; -.
DR   Ensembl; ENST00000332272; ENSP00000328983; ENSG00000183196.
DR   Ensembl; ENST00000390664; ENSP00000375079; ENSG00000183196.
DR   GeneID; 4166; -.
DR   KEGG; hsa:4166; -.
DR   UCSC; uc002fef.4; human.
DR   CTD; 4166; -.
DR   DisGeNET; 4166; -.
DR   GeneCards; CHST6; -.
DR   HGNC; HGNC:6938; CHST6.
DR   MalaCards; CHST6; -.
DR   MIM; 217800; phenotype.
DR   MIM; 605294; gene.
DR   neXtProt; NX_Q9GZX3; -.
DR   OpenTargets; ENSG00000183196; -.
DR   Orphanet; 98969; Macular corneal dystrophy.
DR   PharmGKB; PA26506; -.
DR   eggNOG; ENOG410IJXD; Eukaryota.
DR   eggNOG; ENOG4110V0B; LUCA.
DR   GeneTree; ENSGT00530000062902; -.
DR   HOGENOM; HOG000261614; -.
DR   HOVERGEN; HBG050949; -.
DR   InParanoid; Q9GZX3; -.
DR   KO; K09671; -.
DR   OMA; NGFTWAS; -.
DR   OrthoDB; EOG091G0V3Y; -.
DR   PhylomeDB; Q9GZX3; -.
DR   TreeFam; TF342871; -.
DR   Reactome; R-HSA-2022854; Keratan sulfate biosynthesis.
DR   ChiTaRS; CHST6; human.
DR   GeneWiki; CHST6; -.
DR   GenomeRNAi; 4166; -.
DR   PRO; PR:Q9GZX3; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000183196; -.
DR   CleanEx; HS_CHST6; -.
DR   Genevisible; Q9GZX3; HS.
DR   GO; GO:0005794; C:Golgi apparatus; TAS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0001517; F:N-acetylglucosamine 6-O-sulfotransferase activity; IDA:UniProtKB.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0018146; P:keratan sulfate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006044; P:N-acetylglucosamine metabolic process; IDA:UniProtKB.
DR   GO; GO:0006790; P:sulfur compound metabolic process; IDA:UniProtKB.
DR   InterPro; IPR016469; Carbohydrate_sulfotransferase.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000863; Sulfotransferase_dom.
DR   Pfam; PF00685; Sulfotransfer_1; 1.
DR   PIRSF; PIRSF005883; Carbohydrate_sulfotransferase; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
PE   1: Evidence at protein level;
KW   Carbohydrate metabolism; Complete proteome; Corneal dystrophy;
KW   Disease mutation; Glycoprotein; Golgi apparatus; Membrane;
KW   Polymorphism; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    395       Carbohydrate sulfotransferase 6.
FT                                /FTId=PRO_0000085197.
FT   TOPO_DOM      1      5       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      6     26       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     27    395       Lumenal. {ECO:0000255}.
FT   NP_BIND      49     55       PAPS. {ECO:0000250}.
FT   NP_BIND     202    210       PAPS. {ECO:0000250}.
FT   CARBOHYD    116    116       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    229    229       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    305    305       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    328    328       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      15     15       L -> P (in MCD).
FT                                {ECO:0000269|PubMed:12824236}.
FT                                /FTId=VAR_021417.
FT   VARIANT      22     22       L -> R (in MCD; dbSNP:rs68043642).
FT                                {ECO:0000269|PubMed:14609920}.
FT                                /FTId=VAR_021418.
FT   VARIANT      31     31       P -> S (in MCD; dbSNP:rs72547549).
FT                                {ECO:0000269|PubMed:11818380}.
FT                                /FTId=VAR_021419.
FT   VARIANT      42     42       H -> Y (in MCD).
FT                                {ECO:0000269|PubMed:14609920}.
FT                                /FTId=VAR_021420.
FT   VARIANT      50     50       R -> C (in MCD; abolishes ability to
FT                                sulfate keratan; dbSNP:rs28937877).
FT                                {ECO:0000269|PubMed:11017086,
FT                                ECO:0000269|PubMed:12218059}.
FT                                /FTId=VAR_021421.
FT   VARIANT      51     51       S -> L (in MCD; dbSNP:rs370335460).
FT                                {ECO:0000269|PubMed:12882775,
FT                                ECO:0000269|PubMed:15013869}.
FT                                /FTId=VAR_021422.
FT   VARIANT      52     52       G -> D (in MCD).
FT                                {ECO:0000269|PubMed:14735064}.
FT                                /FTId=VAR_021423.
FT   VARIANT      53     53       S -> L (in MCD).
FT                                {ECO:0000269|PubMed:14609920,
FT                                ECO:0000269|PubMed:14735064}.
FT                                /FTId=VAR_021424.
FT   VARIANT      59     59       L -> P (in MCD).
FT                                {ECO:0000269|PubMed:12882775}.
FT                                /FTId=VAR_021425.
FT   VARIANT      61     61       N -> T (in MCD; dbSNP:rs72547548).
FT                                {ECO:0000269|PubMed:12824236}.
FT                                /FTId=VAR_021426.
FT   VARIANT      66     66       V -> L (in MCD; dbSNP:rs72547547).
FT                                {ECO:0000269|PubMed:12882775}.
FT                                /FTId=VAR_021427.
FT   VARIANT      68     68       Y -> H (in MCD; dbSNP:rs775742450).
FT                                {ECO:0000269|PubMed:12824236}.
FT                                /FTId=VAR_021428.
FT   VARIANT      70     70       M -> L (in MCD).
FT                                {ECO:0000269|PubMed:12824236}.
FT                                /FTId=VAR_021429.
FT   VARIANT      72     72       P -> S (in MCD; dbSNP:rs377617168).
FT                                {ECO:0000269|PubMed:11818380,
FT                                ECO:0000269|PubMed:15013869}.
FT                                /FTId=VAR_021430.
FT   VARIANT      76     76       V -> M (in MCD).
FT                                {ECO:0000269|PubMed:12882775}.
FT                                /FTId=VAR_021431.
FT   VARIANT      93     93       R -> H (in MCD).
FT                                {ECO:0000269|PubMed:14609920}.
FT                                /FTId=VAR_021432.
FT   VARIANT      97     97       R -> P (in MCD; dbSNP:rs72547546).
FT                                {ECO:0000269|PubMed:14609920}.
FT                                /FTId=VAR_021433.
FT   VARIANT      98     98       S -> W (in MCD).
FT                                {ECO:0000269|PubMed:14735064}.
FT                                /FTId=VAR_021434.
FT   VARIANT     102    102       C -> G (in MCD; dbSNP:rs121917822).
FT                                {ECO:0000269|PubMed:12824236,
FT                                ECO:0000269|PubMed:14984470,
FT                                ECO:0000269|PubMed:15013869}.
FT                                /FTId=VAR_021435.
FT   VARIANT     102    102       C -> Y (in MCD).
FT                                {ECO:0000269|PubMed:14609920}.
FT                                /FTId=VAR_021436.
FT   VARIANT     104    104       M -> V (in MCD).
FT                                {ECO:0000269|PubMed:15013869}.
FT                                /FTId=VAR_021437.
FT   VARIANT     107    107       F -> S (in MCD; dbSNP:rs72547545).
FT                                {ECO:0000269|PubMed:11818380,
FT                                ECO:0000269|PubMed:14735064}.
FT                                /FTId=VAR_021438.
FT   VARIANT     110    110       Y -> C (in MCD; dbSNP:rs72547544).
FT                                {ECO:0000269|PubMed:15013869}.
FT                                /FTId=VAR_021439.
FT   VARIANT     118    118       S -> F (in MCD; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:26604660}.
FT                                /FTId=VAR_075522.
FT   VARIANT     121    121       F -> L (in MCD).
FT                                {ECO:0000269|PubMed:14735064}.
FT                                /FTId=VAR_021440.
FT   VARIANT     122    122       Q -> P (in MCD; dbSNP:rs758105699).
FT                                {ECO:0000269|PubMed:15013869}.
FT                                /FTId=VAR_021441.
FT   VARIANT     127    127       R -> C (in MCD).
FT                                {ECO:0000269|PubMed:14609920}.
FT                                /FTId=VAR_021442.
FT   VARIANT     128    128       A -> V (in MCD; dbSNP:rs72547543).
FT                                {ECO:0000269|PubMed:11139648}.
FT                                /FTId=VAR_021443.
FT   VARIANT     131    131       S -> P (in MCD).
FT                                {ECO:0000269|PubMed:12824236}.
FT                                /FTId=VAR_021444.
FT   VARIANT     152    152       L -> P (in MCD; dbSNP:rs142954809).
FT                                {ECO:0000269|PubMed:12824236}.
FT                                /FTId=VAR_021445.
FT   VARIANT     162    162       R -> G (in MCD; dbSNP:rs117435647).
FT                                {ECO:0000269|PubMed:14984470}.
FT                                /FTId=VAR_021446.
FT   VARIANT     166    166       R -> P (in MCD; dbSNP:rs72547542).
FT                                {ECO:0000269|PubMed:11139648,
FT                                ECO:0000269|PubMed:12824236}.
FT                                /FTId=VAR_021447.
FT   VARIANT     174    174       K -> R (in MCD; abolishes ability to
FT                                sulfate keratan; dbSNP:rs28937878).
FT                                {ECO:0000269|PubMed:11017086,
FT                                ECO:0000269|PubMed:12218059,
FT                                ECO:0000269|PubMed:26604660}.
FT                                /FTId=VAR_021448.
FT   VARIANT     177    177       R -> G (in MCD).
FT                                {ECO:0000269|PubMed:21242781}.
FT                                /FTId=VAR_075523.
FT   VARIANT     177    177       R -> H (in MCD).
FT                                {ECO:0000269|PubMed:12882769}.
FT                                /FTId=VAR_021449.
FT   VARIANT     186    186       P -> R (in MCD; dbSNP:rs376162109).
FT                                {ECO:0000269|PubMed:21242781,
FT                                ECO:0000269|PubMed:26604660}.
FT                                /FTId=VAR_075524.
FT   VARIANT     198    198       V -> E (in MCD).
FT                                {ECO:0000269|PubMed:14984470}.
FT                                /FTId=VAR_021450.
FT   VARIANT     200    200       L -> R (in MCD; dbSNP:rs28937879).
FT                                {ECO:0000269|PubMed:11818380,
FT                                ECO:0000269|PubMed:12824236,
FT                                ECO:0000269|PubMed:14984470,
FT                                ECO:0000269|PubMed:15013869,
FT                                ECO:0000269|PubMed:15652851}.
FT                                /FTId=VAR_021451.
FT   VARIANT     202    202       R -> S (in MCD).
FT                                {ECO:0000269|PubMed:14735064}.
FT                                /FTId=VAR_021452.
FT   VARIANT     203    203       D -> E (in MCD; abolishes ability to
FT                                sulfate keratan; dbSNP:rs28937878).
FT                                {ECO:0000269|PubMed:11017086,
FT                                ECO:0000269|PubMed:12218059}.
FT                                /FTId=VAR_021453.
FT   VARIANT     204    204       P -> Q (in MCD; dbSNP:rs759870075).
FT                                {ECO:0000269|PubMed:12824236,
FT                                ECO:0000269|PubMed:12882769,
FT                                ECO:0000269|PubMed:14735064}.
FT                                /FTId=VAR_021454.
FT   VARIANT     205    205       R -> L (in MCD).
FT                                {ECO:0000269|PubMed:12882769}.
FT                                /FTId=VAR_021455.
FT   VARIANT     205    205       R -> Q (in MCD; dbSNP:rs377706989).
FT                                {ECO:0000269|PubMed:14609920}.
FT                                /FTId=VAR_021456.
FT   VARIANT     205    205       R -> W (in MCD; dbSNP:rs750219546).
FT                                {ECO:0000269|PubMed:24311932,
FT                                ECO:0000269|PubMed:26604660}.
FT                                /FTId=VAR_075525.
FT   VARIANT     206    206       A -> T (in MCD; dbSNP:rs374493344).
FT                                {ECO:0000269|PubMed:14609920}.
FT                                /FTId=VAR_021457.
FT   VARIANT     206    206       A -> V (in MCD).
FT                                {ECO:0000269|PubMed:11818380}.
FT                                /FTId=VAR_021458.
FT   VARIANT     210    210       S -> F (in MCD; dbSNP:rs745571211).
FT                                {ECO:0000269|PubMed:14735064}.
FT                                /FTId=VAR_021459.
FT   VARIANT     211    211       R -> Q (in MCD; dbSNP:rs771397083).
FT                                {ECO:0000269|PubMed:12882775,
FT                                ECO:0000269|PubMed:12883341,
FT                                ECO:0000269|PubMed:21242781}.
FT                                /FTId=VAR_021460.
FT   VARIANT     211    211       R -> W (in MCD; abolishes ability to
FT                                sulfate keratan; dbSNP:rs202175444).
FT                                {ECO:0000269|PubMed:11017086,
FT                                ECO:0000269|PubMed:12218059,
FT                                ECO:0000269|PubMed:12882769}.
FT                                /FTId=VAR_021461.
FT   VARIANT     217    217       A -> T (in MCD; abolishes ability to
FT                                sulfate keratan; dbSNP:rs752785520).
FT                                {ECO:0000269|PubMed:12218059,
FT                                ECO:0000269|PubMed:12882769}.
FT                                /FTId=VAR_021462.
FT   VARIANT     221    221       D -> E (in MCD).
FT                                {ECO:0000269|PubMed:14735064}.
FT                                /FTId=VAR_021463.
FT   VARIANT     221    221       D -> Y (in MCD).
FT                                {ECO:0000269|PubMed:14735064}.
FT                                /FTId=VAR_021464.
FT   VARIANT     249    249       H -> P (in MCD; dbSNP:rs72547540).
FT                                {ECO:0000269|PubMed:14609920}.
FT                                /FTId=VAR_021465.
FT   VARIANT     268    268       Y -> C (in MCD; dbSNP:rs72547539).
FT                                {ECO:0000269|PubMed:12882775}.
FT                                /FTId=VAR_021466.
FT   VARIANT     274    274       E -> K (in MCD; abolishes ability to
FT                                sulfate keratan; dbSNP:rs72547538).
FT                                {ECO:0000269|PubMed:11017086,
FT                                ECO:0000269|PubMed:12218059,
FT                                ECO:0000269|PubMed:14609920,
FT                                ECO:0000269|PubMed:26604660}.
FT                                /FTId=VAR_021467.
FT   VARIANT     276    276       L -> P (in MCD; dbSNP:rs121917824).
FT                                {ECO:0000269|PubMed:15013869,
FT                                ECO:0000269|PubMed:15652851}.
FT                                /FTId=VAR_021468.
FT   VARIANT     308    308       H -> Y (in MCD; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:26604660}.
FT                                /FTId=VAR_075526.
FT   VARIANT     358    358       Y -> D (in MCD).
FT                                {ECO:0000269|PubMed:15652851}.
FT                                /FTId=VAR_021469.
FT   VARIANT     358    358       Y -> H (in MCD).
FT                                {ECO:0000269|PubMed:19365571,
FT                                ECO:0000269|PubMed:26604660}.
FT                                /FTId=VAR_075527.
FT   VARIANT     369    369       N -> D (in dbSNP:rs35036798).
FT                                /FTId=VAR_033735.
SQ   SEQUENCE   395 AA;  44099 MW;  433CA60248A48F67 CRC64;
     MWLPRVSSTA VTALLLAQTF LLLFLVSRPG PSSPAGGEAR VHVLVLSSWR SGSSFVGQLF
     NQHPDVFYLM EPAWHVWTTL SQGSAATLHM AVRDLVRSVF LCDMDVFDAY LPWRRNLSDL
     FQWAVSRALC SPPACSAFPR GAISSEAVCK PLCARQSFTL AREACRSYSH VVLKEVRFFN
     LQVLYPLLSD PALNLRIVHL VRDPRAVLRS REQTAKALAR DNGIVLGTNG TWVEADPGLR
     VVREVCRSHV RIAEAATLKP PPFLRGRYRL VRFEDLAREP LAEIRALYAF TGLSLTPQLE
     AWIHNITHGS GPGARREAFK TSSRNALNVS QAWRHALPFA KIRRVQELCA GALQLLGYRP
     VYSEDEQRNL ALDLVLPRGL NGFTWASSTA SHPRN
//
